Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-γ and negatively with disease activity in SLE

Cytokine

Volumn 10, Issue 2, 1998, Pages 148-153

  Liu, Tie Fu ^a   Jones, Brian M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti ds DNA; Cytokines; IL 12; Lupus; SLEDAI

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032006743     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0269     Document Type: Article

References (32)

1. 1. Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Kreig AM (1991) Systemic lupus erythematosus. Ann Intern Med 115:548-559.
2. 2. Isenberg DA, Dudeney C, Williams W, Todd-Pokropek A, Sollar BD (1988) Disease activity in systemic lupus erythematosus related to a range of antibodies binding DNA and synthetic polynucleotides. Ann Rheum Dis 47:717-724.
3. 3. Hess EV, Farhey Y (1995) Etiology, environmental relationships, epidemiology, and genetics of systemic lupus erythematosus. Curr Opin Rheum 7:371-375.
4. 4. Klinman DM, Stein AD (1995) Inquiry into murine and human lupus. Immunol Reviews 144:157-193.
5. 5. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinberg JR (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis. J Immunol 147:117-123.
6. 6. Richaud-Patin Y, Alcocer-Varela J, Llorente L (1995) High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 47:267-272.
7. 7. Barcellini W, Rizzardi GP, Borghi MO, Nicoletti F, Fain C, Del-Papa N, Meroni PL (1996) In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 5:139-145.
8. 8. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647-1655.
9. 9. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839-844.
10. 10. Kitani A, Hara M, Hirose T, Harigai M, Suzuki K, Kawakami M, Kawaguchi Y, Hidaka T, Kawagoe M, Nakamura H (1992) Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 88:75-83.
11. 11. Al-Janadi M, Raziuddin S (1993) B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 20:1885-1891.
12. 12. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G (1994) Interleukin-12 induces stable priming for interferon-γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J Exp Med 179:1237-1283.
13. 13. Kennedy MK, Picha KS, Shanebeck KD, Anderson DM, Grabstein KH (1994) Interleukin-12 regulates proliferation of Th1, but not Th2 or Th0 clones. Eur J Immunol 24: 2271-2278.
14. 14. Oswald IP, Caspar P, Jankovic D, Wynn TA, Pearce EJ, Sher A (1994) IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J Immunol 153:1707-1713.
15. 15. Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR (1995) IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol 154:1491-1498.
16. 16. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995) Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821.
17. 17. Leonard JP, Waldburger KE, Goldman SJ (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181:381-386.
18. 18. Liu TF, Jones BM (1998) Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes Cytokine 10:140-147.
19. 19. Snijders A, Hilkens CMU, Van Der Pouw Kraan TCTM, Engel M, Aarden LA, Kapsenberg ML (1996) Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol 156:1207-1212.
20. 20. Chensue SW, Ruth JH, Warmington K, Lincoln P, Kunkel SL (1995) In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol 155:3546-3551.
21. 21. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK (1996) Regulation of murine macrophage IL-12 production. J Immunol 156:1196-1206.
22. 22. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune disease and probes for cell biology. Adv Immunol 4:93-151.
23. 23. Spronk PE, Limburg PC, Kallenberg CG (1995) Serological markers of disease activity in systemic lupus erythematosus. Lupus 4:86-94.
24. 24. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Fourrier BM, Galanaud P, Emilie D (1993) Spontaneous production of interleukin 10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4:421-427.
25. 25. Houssiau FA, Lefebvre C, Berghe MV, Lambert M, Devogelaer J-P, Renauld J-C (1995) Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4:393-395.
26. 26. Hagiwara E, Gourley MF, Lee S, Klinman DK (1996) Disease activity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 39:379-385.
27. 27. Ter-Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM (1990) Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study. Arthritis Rhem 33:634-643.
28. 28. Isenberg DA, Colaco CB, Dudeney C, Todd-Pokropek A, Snaith ML (1986) The relationship of anti-DNA antibody idiotypes and cardiolipin antibodies to disease activity in systemic lupus erythematosus. Medicine 65:46-55.
29. 29. McGrath H, Biundo JJ (1985) A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus. Arthritis Rheum 28:425-430.
30. 30. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277.
31. 31. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, The Committe on Prognosis Studies in SLE (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Reum 35:630-640.
32. 32. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87:6808-6812.